442 related articles for article (PubMed ID: 24633558)
21. Cannabis use in youth is associated with limited alterations in brain structure.
Scott JC; Rosen AFG; Moore TM; Roalf DR; Satterthwaite TD; Calkins ME; Ruparel K; Gur RE; Gur RC
Neuropsychopharmacology; 2019 Jul; 44(8):1362-1369. PubMed ID: 30780151
[TBL] [Abstract][Full Text] [Related]
22. Structural brain abnormalities correlate with clinical features in patients with drug-naïve OCD: A DARTEL-enhanced voxel-based morphometry study.
Tang W; Huang X; Li B; Jiang X; Li F; Xu J; Yang Y; Gong Q
Behav Brain Res; 2015 Nov; 294():72-80. PubMed ID: 26241173
[TBL] [Abstract][Full Text] [Related]
23. Preliminary findings demonstrating latent effects of early adolescent marijuana use onset on cortical architecture.
Filbey FM; McQueeny T; DeWitt SJ; Mishra V
Dev Cogn Neurosci; 2015 Dec; 16():16-22. PubMed ID: 26507433
[TBL] [Abstract][Full Text] [Related]
24. Cannabis use and brain structural alterations of the cingulate cortex in early psychosis.
Rapp C; Walter A; Studerus E; Bugra H; Tamagni C; Röthlisberger M; Borgwardt S; Aston J; Riecher-Rössler A
Psychiatry Res; 2013 Nov; 214(2):102-8. PubMed ID: 24054726
[TBL] [Abstract][Full Text] [Related]
25. Grey Matter Changes Associated with Heavy Cannabis Use: A Longitudinal sMRI Study.
Koenders L; Cousijn J; Vingerhoets WA; van den Brink W; Wiers RW; Meijer CJ; Machielsen MW; Veltman DJ; Goudriaan AE; de Haan L
PLoS One; 2016; 11(5):e0152482. PubMed ID: 27224247
[TBL] [Abstract][Full Text] [Related]
26. Young brains on drugs.
DuPont RL; Lieberman JA
Science; 2014 May; 344(6184):557. PubMed ID: 24812368
[No Abstract] [Full Text] [Related]
27. Orbitofrontal cortex volume prospectively predicts cannabis and other substance use onset in adolescents.
Wade NE; Bagot KS; Cota CI; Fotros A; Squeglia LM; Meredith LR; Jacobus J
J Psychopharmacol; 2019 Sep; 33(9):1124-1131. PubMed ID: 31215833
[TBL] [Abstract][Full Text] [Related]
28. Gray matter changes in chronic heavy cannabis users: a voxel-level study using multivariate pattern analysis approach.
Wu YF; Yang B
Neuroreport; 2020 Dec; 31(17):1236-1241. PubMed ID: 33044327
[TBL] [Abstract][Full Text] [Related]
29. Cannabis cue-induced brain activation correlates with drug craving in limbic and visual salience regions: preliminary results.
Charboneau EJ; Dietrich MS; Park S; Cao A; Watkins TJ; Blackford JU; Benningfield MM; Martin PR; Buchowski MS; Cowan RL
Psychiatry Res; 2013 Nov; 214(2):122-31. PubMed ID: 24035535
[TBL] [Abstract][Full Text] [Related]
30. Fronto-temporal cortical atrophy in 'nyaope' combination heroin and cannabis use disorder.
Ndlovu NA; Morgan N; Malapile S; Subramaney U; Daniels W; Naidoo J; van den Heuvel MP; Calvey T
Drug Alcohol Depend; 2021 Apr; 221():108630. PubMed ID: 33667779
[TBL] [Abstract][Full Text] [Related]
31. Cannabis use and memory brain function in adolescent boys: a cross-sectional multicenter functional magnetic resonance imaging study.
Jager G; Block RI; Luijten M; Ramsey NF
J Am Acad Child Adolesc Psychiatry; 2010 Jun; 49(6):561-72, 572.e1-3. PubMed ID: 20494266
[TBL] [Abstract][Full Text] [Related]
32. Cannabis and the developing brain: What does the evidence say?
Jacobus J; Courtney KE; Hodgdon EA; Baca R
Birth Defects Res; 2019 Oct; 111(17):1302-1307. PubMed ID: 31385460
[TBL] [Abstract][Full Text] [Related]
33. The relation between gray matter volume and the use of alcohol, tobacco, cocaine and cannabis in male polysubstance users.
Kaag AM; Schulte MHJ; Jansen JM; van Wingen G; Homberg J; van den Brink W; Wiers RW; Schmaal L; Goudriaan AE; Reneman L
Drug Alcohol Depend; 2018 Jun; 187():186-194. PubMed ID: 29679913
[TBL] [Abstract][Full Text] [Related]
34. Cortical and Subcortical Gray Matter Volume in Youths With Conduct Problems: A Meta-analysis.
Rogers JC; De Brito SA
JAMA Psychiatry; 2016 Jan; 73(1):64-72. PubMed ID: 26650724
[TBL] [Abstract][Full Text] [Related]
35. Adverse Structural and Functional Effects of Marijuana on the Brain: Evidence Reviewed.
Mandelbaum DE; de la Monte SM
Pediatr Neurol; 2017 Jan; 66():12-20. PubMed ID: 27789118
[TBL] [Abstract][Full Text] [Related]
36. Multiple sclerosis, cannabis, and cognition: A structural MRI study.
Romero K; Pavisian B; Staines WR; Feinstein A
Neuroimage Clin; 2015; 8():140-7. PubMed ID: 26106538
[TBL] [Abstract][Full Text] [Related]
37. Altered resting-state connectivity in adolescent cannabis users.
Orr C; Morioka R; Behan B; Datwani S; Doucet M; Ivanovic J; Kelly C; Weierstall K; Watts R; Smyth B; Garavan H
Am J Drug Alcohol Abuse; 2013 Nov; 39(6):372-81. PubMed ID: 24200207
[TBL] [Abstract][Full Text] [Related]
38. Greater white and grey matter changes associated with early cannabis use in adolescent-onset schizophrenia (AOS).
James A; Hough M; James S; Winmill L; Burge L; Nijhawan S; Matthews PM; Zarei M
Schizophr Res; 2011 May; 128(1-3):91-7. PubMed ID: 21388791
[TBL] [Abstract][Full Text] [Related]
39. [18F]MK-9470 PET measurement of cannabinoid CB1 receptor availability in chronic cannabis users.
Ceccarini J; Kuepper R; Kemels D; van Os J; Henquet C; Van Laere K
Addict Biol; 2015 Mar; 20(2):357-67. PubMed ID: 24373053
[TBL] [Abstract][Full Text] [Related]
40. Cannabis and the maturing brain: Role in psychosis development.
Crocker CE; Tibbo PG
Clin Pharmacol Ther; 2015 Jun; 97(6):545-7. PubMed ID: 25704358
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
